JNCCN: Improving COVID-19 safety for cancer patients and healthcare providers

April 09, 2020

PLYMOUTH MEETING, PA [April 9, 2020] -- The National Comprehensive Cancer Network® (NCCN®)--an alliance of leading cancer centers--is continuing to share new resources for optimal cancer management amid new and changing challenges related to the Coronavirus Disease 2019 (COVID-19). The nonprofit organization's Best Practices Committee has published a new article online-ahead-of-print in JNCCN--Journal of the National Comprehensive Cancer Network detailing their recommendations for keeping cancer patients, caregivers and staff as safe as possible.

"The unprecedented challenges we are all facing from the COVID-19 pandemic heighten NCCN's commitment to sharing evidence-based consensus from leading medical experts as rapidly as possible, free-of-charge, to everyone around the world," said Robert W. Carlson, MD, Chief Executive Officer, NCCN. "We are doing everything we can to review and share reliable information that will help keep oncology patients, providers, and staff safe under the new reality of increased risk."

"We can continue to provide our patients with effective and compassionate care, without sacrificing the health and safety of our teams, colleagues, and families, by carefully evaluating any emerging research and modifying our treatment approaches accordingly," said lead author Pelin Cinar, MD, MS, UCSF Helen Diller Family Comprehensive Cancer Center. "People with cancer and their loved ones already go through so much, and now they face new fears around catching COVID-19 or delaying necessary treatment. By sharing these recommendations, we want to reassure the oncology community that there are some aspects of care that we can and will control in order to improve outcomes for people with cancer."

The JNCCN article contains the most current information at the time of publication, but notes that recommendations regarding public safety and practice may change rapidly; individuals can also keep up with the most up-to-date information via the CDC website.

The NCCN Best Practices Committee recommendations can be summarized as follows:

Patient Safety

Healthcare Worker Safety

The full article can be found at: https://jnccn.org/page/May%20Special%20Feature%20on%20COVID-19%20/new-special-feature-on-covid19.

In addition to Dr. Cinar, the article includes authors from Abramson Cancer Center at the University of Pennsylvania, Duke Cancer Institute, Fred & Pamela Buffett Cancer Center, Mayo Clinic Cancer Center, Moffitt Cancer Center, Ohio State Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Seattle Cancer Care Alliance (including Fred Hutchinson Research Center and University of Washington), University of Colorado Cancer Center, and Yale Cancer Center/Smilow Cancer Hospital.

Meanwhile, NCCN continues to add to, and update, the growing list of free resources available at NCCN.org/covid-19. Recently-published items include:

GeneralTreatment of Cancer by SiteScreening and Early DetectionSupportive CareNCCN remains committed to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives under any circumstances. The organization has continued posting new updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)--which contain optimal recommendations for normal resource levels in the United States--while also sharing new shorter term guidance for adjusting cancer care during the COVID-19 pandemic. NCCN's Global Program also provides guidelines to account for differing regional resource levels and non-English languages, while the NCCN Foundation® provides funding for versions in non-medical language for patients and caregivers. The NCCN Guidelines® are always available free-of-charge for non-commercial use at NCCN.org (free registration required) or via the Virtual Library of NCCN Guidelines® App.
About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of 30 leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. By defining and advancing high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers around the world.

Clinicians, visit NCCN.org. Patients and caregivers, visit NCCN.org/patients. Media, visit NCCN.org/news. Follow NCCN on Twitter @NCCN, Facebook @NCCNorg, and Instagram @NCCNorg.

National Comprehensive Cancer Network

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.